Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
6.12
+0.31 (5.34%)
At close: Sep 11, 2026, 4:00 PM EDT
6.11
-0.01 (-0.16%)
After-hours: Sep 11, 2026, 7:30 PM EDT
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $367.84 million as of September 11, 2026. Its market cap has increased by 161.21% in one year.
Market Cap
367.84M
Enterprise Value
328.64M
1-Year Change
161.21%
Ranking
Category
Stock Price
$6.12
ChartMarket Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $197.44M to $367.84M, an increase of 86.30%. That is a compound annual growth rate of 10.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 367.84M | 56.98% |
| Dec 31, 2025 | 234.33M | 54.11% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Compass Therapeutics | 369.18M |
| EyePoint | 366.40M |
| Lexeo Therapeutics | 357.70M |
| Century Therapeutics | 351.29M |
| Palisade Bio | 350.28M |
| DiaMedica Therapeutics | 348.90M |
| Ocugen | 347.59M |
| Sionna Therapeutics | 344.52M |